Posts
Reddit userbase capitalization
We always talk about numbers and financials but in case of reddit I feel they have fundamental concern about how to capitalize the userbase and convert it into the revenue. USP of reddit which is chaotic, equivocal, intelligent and freevoice userbase is itself their problem. On other platforms like Facebook …
What are some memorable management calls you’ve learned from?
Ive been taking away a lot from earnings calls and the Q&As, both: 1. in terms of understanding the actual business and, 2. professionally, learning how good management teams communicate, handle tough questions, and present results. Are there any memorable earnings calls or Q&As you would recomend where you learned …
$WU: Value Trap, or Deep Value Cash Cow (With A Twist)?
# What some see as a value trap I believe is becoming a deep value buy, a wealth of opportunities. Along with this cash 🐄 having an attractive dividend yield, you can collect premiums by selling covered calls (CCs). After a \~17.3% drop yesterday, a huge overreaction to the earnings …
First Investment Analysis - Misunderstood UK House Builder
As mentioned this is my first investment analysis of a stock so feel free to question and pull apart my arguments. Interested in anything people have to say! The stock is Vistry Plc (LSE: VTY). At a time when everyone is seemingly losing their minds over AI stocks and IPOs …
How do you calculate your return?
With cash inputs/outputs, dividends, stock splits and spin-offs, it's extremely difficult to calculate a return/year imo. So my simple question is: how do you do it ?
Micron at P/E 18 vs Meta at P/E 20 - is there value here?
Thinking about selling some win from S&P ETF and buy one of the two, possibly for the next 5Y. Are they well positioned to beat the market? Alternative is to buy GEV, which I believe cold be successful in the next 5Y and -possibly- more recession proof than tech. Another …
Tell me I shouldn't buy more CAT. Think I'm gonna tho
Picks and shovels, plain and simple. Nice little dip. Might double down.
Third Round of My Research on RMD | The Moat Is Not the Devices!!
When I started researching ResMed (RMD), I thought I was analysing a medical device company. The debate seemed simple: Philips lost share after the recall, Fisher & Paykel is a capable competitor, and GLP 1 drugs may reduce future sleep apnea demand. After working through more than twenty questions design …
What to do When a Discounted Stock becomes Fair Valued?
Microsoft was clearly an undervalued play prior to earnings, I bought roughly 225 shares as a cost basis of 387. After the amazing earnings this position is up over 20% in just a week moving it very quickly from undervalued to in my opinion fair valued. My question is then. …